Literature DB >> 26873518

Diagnosis and Treatment of Hemoptysis.

Rosa Cordovilla1, Elena Bollo de Miguel2, Ana Nuñez Ares3, Francisco Javier Cosano Povedano4, Inmaculada Herráez Ortega5, Rafael Jiménez Merchán6.   

Abstract

Hemoptysis is the expectoration of blood from the tracheobronchial tree. It is commonly caused by bronchiectasis, chronic bronchitis, and lung cancer. The expectorated blood usually originates from the bronchial arteries. When hemoptysis is suspected, it must be confirmed and classified according to severity, and the origin and cause of the bleeding determined. Lateral and AP chest X-ray is the first study, although a normal chest X-ray does not rule out the possibility of malignancy or other underlying pathology. Multidetector computed tomography (MDCT) must be performed in all patients with frank hemoptysis, hemoptoic sputum, suspicion of bronchiectasis or risk factors for lung cancer, and in those with signs of pathology on chest X-ray. MDCT angiography has replaced arteriography in identifying the arteries that are the source of bleeding. MDCT angiography is a non-invasive imaging technique that can pinpoint the presence, origin, number and course of the systemic thoracic (bronchial and non-bronchial) and pulmonary arterial sources of bleeding. Endovascular embolization is the safest and most effective method of managing bleeding in massive or recurrent hemoptysis. Embolization is indicated in all patients with life-threatening or recurrent hemoptysis in whom MDCT angiography shows artery disease. Flexible bronchoscopy plays a pivotal role in the diagnosis of hemoptysis in patients with hemoptoic sputum or frank hemoptysis. The procedure can be performed rapidly at the bedside (intensive care unit); it can be used for immediate control of bleeding, and is also effective in locating the source of the hemorrhage. Flexible bronchoscopy is the first-line procedure of choice in hemodynamically unstable patients with life-threatening hemoptysis, in whom control of bleeding is of vital importance. In these cases, surgery is associated with an extremely high mortality rate, and is currently only indicated when bleeding is secondary to surgery and its source can be accurately and reliably located.
Copyright © 2016 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Bronchoscopy; Broncoscopia; Hemoptisis; Hemoptisis amenazante; Hemoptysis; Interventional radiology; Life-threatening hemoptysis; Radiología intervencionista

Mesh:

Substances:

Year:  2016        PMID: 26873518     DOI: 10.1016/j.arbres.2015.12.002

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  10 in total

1.  Intrapulmonary mature cystic teratoma presenting with haemoptysis treated with right middle lobectomy in a low-resource setting.

Authors:  Vijay Anand Ismavel; Ann Miriam
Journal:  BMJ Case Rep       Date:  2022-07-14

2.  Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis.

Authors:  Ting-Ting Jiang; Li-Ying Shi; Li-Liang Wei; Xiang Li; Su Yang; Chong Wang; Chang-Ming Liu; Zhong-Liang Chen; Hui-Hui Tu; Zhong-Jie Li; Ji-Cheng Li
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

3.  Outcomes and Complications of Bronchial Angioembolization in Patients with Massive Hemoptysis.

Authors:  Seyed Reza Seyyedi; Parham Sadeghipour; Makan Sadr; Omid Shafe; Jamal Moosavi; Oldooz Aloosh; Atefeh Abedini; Babak Sharif-Kashani
Journal:  Tanaffos       Date:  2019-04

4.  SEPAR and AEER consensus recommendations on the Use of Bronchoscopy and Airway Sampling in Patients with Suspected or Confirmed COVID-19 Infection.

Authors:  Rosa Cordovilla; Susana Álvarez; Liliana Llanos; Ana Nuñez Ares; Enrique Cases Viedma; David Díaz-Pérez; Javier Flandes
Journal:  Arch Bronconeumol       Date:  2020-03-31       Impact factor: 4.872

5.  The Effectiveness of Gelfoam as the Sole and Primary Embolization Agent in the Management of Hemoptysis: A Retrospective Study from a Tertiary Care Center.

Authors:  Abhinandan Ruge; Nidhi Kumar; Clyde Menezes
Journal:  J Clin Imaging Sci       Date:  2021-02-25

Review 6.  Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors.

Authors:  Yasushi Kimura; Mario Ghosn; Waseem Cheema; Prasad S Adusumilli; Stephen B Solomon; Govindarajan Srimathveeralli
Journal:  Mol Ther Oncolytics       Date:  2021-12-21       Impact factor: 7.200

7.  The etiology, clinical profile, and outcome of diffuse alveolar hemorrhage in children: a ten-year single-center experience.

Authors:  Yuanyuan Qi; Libo Wang; Liling Qian; Xiaobo Zhang
Journal:  Transl Pediatr       Date:  2021-11

8.  CIRSE Standards of Practice on Bronchial Artery Embolisation.

Authors:  Joachim Kettenbach; Harald Ittrich; Jean Yves Gaubert; Bernhard Gebauer; Jan Albert Vos
Journal:  Cardiovasc Intervent Radiol       Date:  2022-04-08       Impact factor: 2.740

9.  Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study.

Authors:  Huu Y Le; Van Nam Le; Ngoc Hung Pham; Anh Tuan Phung; Thanh Tung Nguyen; Quyet Do
Journal:  BMC Pulm Med       Date:  2020-08-31       Impact factor: 3.317

10.  A novel approach to the diagnosis and treatment of hemoptysis in infants: A case series.

Authors:  S Javed Zaidi; Lorene Schweig; Dhaval Patel; Alexander Javois; Javeed Akhter
Journal:  Pediatr Pulmonol       Date:  2018-09-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.